Jesuchristopher Joseph

Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer

M. Ebert, B. Ylstra, Laurens G. van der Flier, 2017, Oncotarget.

Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images

William J. Howat, Arvydas Laurinavicius, Renaldas Augulis, 2019, Scientific Reports.

Multiplex Immunohistochemistry: The Importance of Staining Order When Producing a Validated Protocol

G. Ashton, W. Howat, J. Ashton, 2019 .

Changes in Immune Cell Types with Age in Breast are Consistent with a Decline in Immune Surveillance and Increased Immunosuppression

Rosalyn W. Sayaman, V. Seewaldt, Arrianna Zirbes, 2021, Journal of Mammary Gland Biology and Neoplasia.

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

M. Esteller, E. McDermott, K. Jirström, 2017, BMC Medicine.

Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer.

S. Chin, C. Caldas, E. Provenzano, 2017, Cancer research.

Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma

M. Warren, J. J. van den Oord, J. Wouters, 2020, Cell Death & Disease.

Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma

M. Warren, J. J. van den Oord, J. Wouters, 2020, Cell Death & Disease.